{
    "thread": {
        "uuid": "8df027e68dab6e7bd5bb6fdbe7808088e6377750",
        "url": "https://www.prnewswire.com/news-releases/la-fda-aprueba-un-nuevo-antibiotico-para-tres-usos-distintos-850842700.html",
        "site_full": "www.prnewswire.com",
        "site": "prnewswire.com",
        "site_section": "https://prnewswire.com/news-releases/photos/photos-list",
        "site_categories": [
            "media"
        ],
        "section_title": "All Photos News from PR Newswire",
        "title": "La FDA aprueba un nuevo antibiótico para tres usos distintos",
        "title_full": "La FDA aprueba un nuevo antibiótico para tres usos distintos",
        "published": "2024-04-04T21:27:00.000+03:00",
        "replies_count": 0,
        "participants_count": 1,
        "site_type": "news",
        "country": "US",
        "main_image": "https://mma.prnewswire.com/media/317925/FDA_Logo.jpg?p=facebook",
        "performance_score": 0,
        "domain_rank": 191,
        "domain_rank_updated": "2024-04-02T13:08:08.000+03:00",
        "reach": null,
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "gplus": {
                "shares": 0
            },
            "pinterest": {
                "shares": 0
            },
            "linkedin": {
                "shares": 0
            },
            "stumbledupon": {
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "8df027e68dab6e7bd5bb6fdbe7808088e6377750",
    "url": "https://www.prnewswire.com/news-releases/la-fda-aprueba-un-nuevo-antibiotico-para-tres-usos-distintos-850842700.html",
    "ord_in_thread": 0,
    "parent_url": null,
    "author": "U.S. Food and Drug Administration",
    "published": "2024-04-04T21:27:00.000+03:00",
    "title": "La FDA aprueba un nuevo antibiótico para tres usos distintos",
    "text": "In English SILVER SPRING, Md., 4 de abril de 2024 /PRNewswire-HISPANIC PR WIRE/ — Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) ha aprobado Zevtera (ceftobiprol medocaril sódico inyectable) para el tratamiento de adultos con…\nSource link",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "spanish",
    "sentiment": "positive",
    "categories": [
        "Health"
    ],
    "external_links": [
        "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=3201433668&u=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-approves-new-antibiotic-three-different-uses&a=In+English",
        "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=3002795324&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT00326287&a=estudio",
        "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=2878173502&u=https%3A%2F%2Fwww.fda.gov%2FEspanol&a=www.FDA.gov%2F",
        "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=1922420250&u=https%3A%2F%2Fwww.fda.gov%2FEspanol&a=Espanol",
        "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=345627293&u=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Fla-fda-aprueba-un-nuevo-antibiotico-para-tres-usos-distintos&a=aprobado",
        "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=2120478660&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03137173&a=estudio",
        "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=181928475&u=https%3A%2F%2Fwww.clinicaltrials.gov%2Fstudy%2FNCT03439124&a=estudio",
        "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=3775414118&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03138733&a=estudio",
        "https://c212.net/c/link/?t=0&l=es&o=4134138-1&h=3859612342&u=https%3A%2F%2Fwww.fda.gov%2Femergency-preparedness-and-response%2Fmcm-issues%2Fantimicrobial-resistance-information-fda&a=Informaci%C3%B3n+sobre+la+resistencia+a+los+antimicrobianos+de+la+FDA",
        "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=3775414118&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03138733&a=estudio",
        "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=3201433668&u=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Ffda-approves-new-antibiotic-three-different-uses&a=In+English",
        "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=2878173502&u=https%3A%2F%2Fwww.fda.gov%2FEspanol&a=www.FDA.gov%2F",
        "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=345627293&u=https%3A%2F%2Fwww.fda.gov%2Fnews-events%2Fpress-announcements%2Fla-fda-aprueba-un-nuevo-antibiotico-para-tres-usos-distintos&a=aprobado",
        "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=1922420250&u=https%3A%2F%2Fwww.fda.gov%2FEspanol&a=Espanol",
        "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=181928475&u=https%3A%2F%2Fwww.clinicaltrials.gov%2Fstudy%2FNCT03439124&a=estudio",
        "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=3002795324&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT00326287&a=estudio",
        "https://c212.net/c/link/",
        "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=2120478660&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT03137173&a=estudio",
        "https://www.c212.net/c/link/?t=0&l=es&o=4134138-1&h=3859612342&u=https%3A%2F%2Fwww.fda.gov%2Femergency-preparedness-and-response%2Fmcm-issues%2Fantimicrobial-resistance-information-fda&a=Informaci%C3%B3n+sobre+la+resistencia+a+los+antimicrobianos+de+la+FDA"
    ],
    "external_images": [],
    "entities": {
        "persons": [],
        "organizations": [],
        "locations": []
    },
    "rating": null,
    "crawled": "2024-04-05T01:29:34.947+03:00",
    "updated": "2024-04-05T04:24:54.096+03:00"
}